What does the evidence say about Creatine Muscle Soreness Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Creatine Muscle Soreness Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Clinically, EIMD is commonly reflected by delayed-onset muscle soreness (DOMS), elevated circulating creatine kinase (CK), and reduced neuromuscular performance []. [Hou Chunlin (2026); evidence level 1] - Massage and cryotherapy have been associated with reductions in DOMS and fatigue [], and massage has also shown favourable effects on short-term recovery of performance []. [Hou Chunlin (2026); evidence level 1] - As a result, interventions that are beneficial immediately after exercise may not retain their effects during delayed recovery. [Hou Chunlin (2026); evidence level 1] - 1 2 1 3 High-intensity training and competitive sport can induce exercise-induced muscle damage (EIMD), characterised by mechanical disruption of sarcomeres, impaired excitation-contraction coupling, and a subsequent inflammatory response [,]. [Hou Chunlin (2026); evidence level 1] - Background/Objectives : Although creatine (Cr) supplementation is well established for enhancing strength exercise adaptations, limited evidence exists regarding whether the timing of a single Cr dose relative to exercise acutely influences performance and related physiological and perceptual responses. [Ben Maaoui K (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.